Quantcast
Channel: BioHealth Investor » Lilly
Browsing all 4 articles
Browse latest View live

Amylin Results Better Than Stock Performance? (AMLN, LLY, ALKS, NVO)

Last night we saw the long-awaited results from Amylin Pharmaceuticals Inc. (NASDAQ: AMLN), Eli Lilly & Co. (NYSE: LLY) and Alkermes Inc. (NASDAQ: ALKS) announce their results from their one-year...

View Article



Is Lilly's Loss Really Others' Gain? (LLY, PFE, BMY, SNE)

Eli Lilly & Co. (NYSE: LLY) is following the lead of Pfizer…. in need of a new breed of drugs, and with shares on the 52-week low list and on a multi-year low list. The FDA has pushed back a...

View Article

E.D. Drugs Causing Amnesia?

There have always been some concerns about side-effects from drugs that treat erectile dysfunction or E.D.  Some are sudden blood pressure drops, hearing loss, and some are erections lasting four hours...

View Article

Trader Take on Dendreon Ahead (DNDN, LLY)

Dendreon Corp. (NASDAQ: DNDN) is so far having very little movement from its presentation at the JPMorgan healthcare conference in San Francisco.  We saw a CNBC interview earlier this week that gave us...

View Article
Browsing all 4 articles
Browse latest View live




Latest Images